Figure 8: Effect of pentoxifylline, diltiazem, and rosuvastatin treatment on TCA (mmol/mg protein) in diabetic and non-diabetic rats. Effect of treatment with pentoxifylline (40 mg/kg, orally), diltiazem (10mg/kg, i.p.), and rosuvastatin (10mg/kg, orally) for 8 weeks on TCA in experimentally STZ induced diabetic nephropathy. Data are presented as mean ± SEM. a: Significant difference versus control group at p < 0.05. b: Significant difference versus diabetic control group at p < 0.05.